54 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Pharma Stock Roundup: AZN & LLY's Q4 Earnings, NVO, NVS & MRK's M&A Deals https://www.zacks.com/stock/news/2224190/pharma-stock-roundup-azn-lly-s-q4-earnings-nvo-nvs-mrk-s-m-a-deals?cid=CS-ZC-FT-analyst_blog|stock_roundup-2224190 Feb 09, 2024 - Eli Lilly (LLY) and AstraZeneca (AZN) announce fourth-quarter results. Novo Nordisk (NVO), Merck (MRK) and Novartis (NVS) make M&A announcements.
Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month https://www.fool.com/investing/2024/02/08/heres-why-merck-eli-lilly-and-novo-nordisk-stocks/?source=iedfolrf0000001 Feb 08, 2024 - Investors are still excited about obesity treatments and weight-management drugs.
ETFs to Buy as Mounjaro Powers Eli Lilly's Q4 Earnings Beat https://www.zacks.com/stock/news/2222669/etfs-to-buy-as-mounjaro-powers-eli-lilly-s-q4-earnings-beat?cid=CS-ZC-FT-etf_news_and_commentary-2222669 Feb 07, 2024 - Eli Lilly and Company (LLY) posted robust fourth-quarter 2023 earnings, beating estimates on both the top and bottom lines driven by strong sales of its diabetes and weight-loss treatments.
Compared to Estimates, Lilly (LLY) Q4 Earnings: A Look at Key Metrics https://www.zacks.com/stock/news/2221950/compared-to-estimates-lilly-lly-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2221950 Feb 06, 2024 - While the top- and bottom-line numbers for Lilly (LLY) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Earnings Data Deluge https://www.zacks.com/stock/news/2221920/earnings-data-deluge?cid=CS-ZC-FT-economic_highlights-2221920 Feb 06, 2024 - Earnings Data Deluge.
Markets Take a Powder; PLTR, NXPI Beat in Q4 https://www.zacks.com/stock/news/2221393/markets-take-a-powder-pltr-nxpi-beat-in-q4?cid=CS-ZC-FT-ahead_of_wall_street-2221393 Feb 05, 2024 - Market indices were reluctant to drag a stock market higher amid all-time high ranges on the Dow and S&P 500.
Drug, Biotech Stocks' Q4 Earnings Due on Feb 6: AMGN, LLY & More https://www.zacks.com/stock/news/2221113/drug-biotech-stocks-q4-earnings-due-on-feb-6-amgn-lly-more?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2221113 Feb 05, 2024 - Let's take a look at four biotech, drug companies, AMGN, LLY, GILD and EXEL, slated to release quarterly results on Feb 6.
Top Stock Reports for Eli Lilly, Danaher & Citigroup https://www.zacks.com/commentary/2220146/top-stock-reports-for-eli-lilly-danaher-citigroup?cid=CS-ZC-FT-research_daily-2220146 Feb 02, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Danaher Corporation (DHR) and Citigroup Inc. (C).
Top Analyst Reports for Eli Lilly, Linde & NextEra Energy https://www.zacks.com/commentary/2211986/top-analyst-reports-for-eli-lilly-linde-nextera-energy?cid=CS-ZC-FT-research_daily-2211986 Jan 18, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Linde plc (LIN) and NextEra Energy, Inc. (NEE).
These Stocks Are Showing Relative Strength as S&P 500 Stalls Near Record High https://www.zacks.com/commentary/2211005/these-stocks-are-showing-relative-strength-as-s-p-500-stalls-near-record-high?cid=CS-ZC-FT-investment_ideas-2211005 Jan 16, 2024 - As investors, our job isn't to predict an unknowable future.

Pages: 123456

<<<Page 3>